Evidence map›Paper›PMID 32471939›Full record

ArticleG3 (Bethesda, Md.)2020

Mingmin Zheng, Tian Yang, Xiaowei Liu, Guihua Lü, Peng Zhang, Bin Jiang, Shufeng Zhou, Yanli Lu, Hai Lan, Suzhi Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Mingmin ZhengMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Tian YangMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Xiaowei LiuMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Guihua LüDongyang Maize Research Institute of Zhejiang Province, Zhejiang Academy of Agricultural Sciences, Dongyang 322100, China.
Peng ZhangMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Bin JiangMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Shufeng ZhouMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Yanli LuMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Hai LanMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Suzhi ZhangMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Chuan LiMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Tingzhao RongMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and.
Moju CaoMaize Research Institute, Sichuan Agricultural University, Chengdu 611130, China and caomj@sicau.edu.cn.
Sichuan Agricultural University · CNDongyang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C-type cytoplasmic male sterility (CMS-C), one of the three major CMS types in maize, has a promising application prospect in hybrid seed production. However, the complex genetic mechanism underlying the fertility restoration of CMS-C remains poorly understood. The maize inbred line A619 is one of the rare strong restorer lines carrying the restorer gene

Indexed as

Infertility, MaleZea maysChromosome MappingFertilityHumansMalePlant InfertilityCytoplasmic male sterilityFertility restorationMaizeQTL-seqRestorer gene

Identifiers

PMID32471939
PMCPMC7341123
OpenAlexW3032303290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.